Derwent London Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Derwent LondonDie Umsatzerlöse des Unternehmens werden voraussichtlich um 1.9% pro Jahr zurückgehen, während die jährlichen Gewinne voraussichtlich um 76.9% pro Jahr wachsen werden. Der Gewinn pro Aktie wird voraussichtlich um 77.3% pro Jahr wachsen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 4.1% betragen.

Wichtige Informationen

81.4%

Wachstumsrate der Gewinne

74.7%

EPS-Wachstumsrate

Office REITs Gewinnwachstum	74.1%
Wachstumsrate der Einnahmen	-2.2%
Zukünftige Eigenkapitalrendite	4.9%
Analystenabdeckung	Good
Zuletzt aktualisiert	13 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Gewinn- und Umsatzwachstumsprognosen

BATS-CHIXE:DLNL - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (GBP Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	248	290	97	158	7
12/31/2025	227	287	38	147	8
12/31/2024	213	110	38	130	8
6/30/2024	279	-361	97	97	N/A
3/31/2024	273	-419	97	97	N/A
12/31/2023	268	-476	97	97	N/A
9/30/2023	265	-518	95	95	N/A
6/30/2023	262	-559	93	93	N/A
3/31/2023	257	-420	102	102	N/A
12/31/2022	251	-280	111	111	N/A
9/30/2022	241	-7	124	124	N/A
6/30/2022	232	267	136	136	N/A
3/31/2022	230	260	133	133	N/A
12/31/2021	228	252	129	129	N/A
9/30/2021	249	152	135	135	N/A
6/30/2021	270	52	141	141	N/A
3/31/2021	269	-13	128	128	N/A
12/31/2020	269	-78	116	116	N/A
9/30/2020	254	32	100	100	N/A
6/30/2020	239	142	84	84	N/A
3/31/2020	235	213	91	91	N/A
12/31/2019	231	283	97	97	N/A
9/30/2019	224	252	92	92	N/A
6/30/2019	217	220	86	86	N/A
3/31/2019	223	221	101	101	N/A
12/31/2018	229	222	115	115	N/A
9/30/2018	228	262	117	117	N/A
6/30/2018	227	302	118	118	N/A
3/31/2018	215	308	N/A	101	N/A
12/31/2017	204	314	N/A	84	N/A
9/30/2017	198	210	N/A	84	N/A
6/30/2017	192	107	N/A	85	N/A
3/31/2017	193	83	N/A	82	N/A
12/31/2016	194	59	N/A	78	N/A
9/30/2016	204	263	N/A	74	N/A
6/30/2016	215	468	N/A	71	N/A
3/31/2016	208	617	N/A	74	N/A
12/31/2015	202	766	N/A	76	N/A
9/30/2015	194	768	N/A	72	N/A
6/30/2015	187	770	N/A	67	N/A
3/31/2015	183	754	N/A	66	N/A
12/31/2014	180	738	N/A	66	N/A
9/30/2014	172	672	N/A	65	N/A
6/30/2014	165	607	N/A	64	N/A
3/31/2014	163	532	N/A	61	N/A
12/31/2013	162	457	N/A	58	N/A
9/30/2013	158	399	N/A	57	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: DLNL wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (1.8%).

Ertrag vs. Markt: DLNL wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: DLNL wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: DLNLDie Einnahmen des Unternehmens werden in den nächsten 3 Jahren voraussichtlich zurückgehen (-1.9% pro Jahr).

Hohe Wachstumseinnahmen: DLNLDie Einnahmen des Unternehmens werden in den nächsten drei Jahren voraussichtlich zurückgehen (-1.9% pro Jahr).

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: DLNLDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (4.1%).

Derwent London Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Derwent London plc Appoints Rob Wilkinson as Non-Executive Director, Member of the Nominations and Audit Committees, Effect from 1 June 2024

Upcoming dividend of UK£0.55 per share

Full year 2023 earnings released: UK£4.24 loss per share (vs UK£2.50 loss in FY 2022)

Insufficient new directors

Final dividend increased to UK£0.55

Full year 2023 earnings released: UK£4.24 loss per share (vs UK£2.50 loss in FY 2022)

Derwent London Plc Announces Final Dividend, Payable on 31 May 2024

Derwent London Plc to Report Q1, 2024 Results on May 09, 2024

Derwent London Plc to Report Fiscal Year 2023 Results on Feb 28, 2024

Derwent London Plc to Report First Half, 2023 Results on Aug 08, 2024

Derwent London Plc(LSE:DLN) dropped from FTSE All-World Index (USD)

Derwent London Plc(LSE:DLN) dropped from FTSE All-World Index (USD)

Upcoming dividend of UK£0.24 per share at 4.3% yield

First half 2023 earnings released: UK£1.28 loss per share (vs UK£1.21 profit in 1H 2022)

Now 22% undervalued after recent price drop

Derwent London Plc to Report Q1, 2023 Results on May 04, 2023

Upcoming dividend of UK£0.55 per share at 3.3% yield

Full year 2022 earnings released: UK£2.50 loss per share (vs UK£2.25 profit in FY 2021)

Full year 2022 earnings released: UK£2.50 loss per share (vs UK£2.25 profit in FY 2021)

An unknown family office advised by Morgan Capital and BNF Capital Limited acquired 63,170 sq ft freehold interest in 19 Charterhouse Street EC1 from Derwent London Plc (LSE:DLN) for £54 million.

An unknown family office advised by Morgan Capital and BNF Capital Limited acquired 63,170 sq ft freehold interest in 19 Charterhouse Street EC1 from Derwent London Plc (LSE:DLN) for £54 million.

Derwent London Plc to Report First Half, 2023 Results on Aug 10, 2023

Investor sentiment deteriorated over the past week

Upcoming dividend of UK£0.24 per share

First half 2022 earnings released

First half 2022 earnings released

Derwent London Plc Proposes Interim Dividend, Payable on October 14, 2022

Derwent London plc Appoints Philippa Davies to Executive Committee

An unknown buyer acquired Bush House, South West Wing WC2 from Derwent London Plc (LSE:DLN) for £85 million.

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Derwent London Plc (LSE:DLN) exchanged a conditional contract to acquire the freehold of City Road Island EC1 from Institute of Ophthalmology, University College London and Moorfields Eye Hospital NHS Foundation Trust for £239 million.

Upcoming dividend of UK£0.54 per share

Full year 2021 earnings released: EPS: UK£2.25 (vs UK£0.69 loss in FY 2020)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Derwent London Plc Proposes Final Dividend, Payable on 1 June 2022

Un unknown buyer acquired New River Yard EC1 in London from Derwent London Plc (LSE:DLN) for £67.5 million.

Un unknown buyer acquired New River Yard EC1 in London from Derwent London Plc (LSE:DLN) for £67.5 million.

Upcoming dividend of UK£0.23 per share

First half 2021 earnings released: EPS UK£1.07 (vs UK£0.085 loss in 1H 2020)

Derwent London Plc (LSE:DLN) acquired Two west end properties in London's Knowledge Quarter from Lazari Investments Ltd.

Derwent London Plc (LSE:DLN) acquired South West Wing of Bush House for £13.5 million.

Tishman Speyer Properties, L.P. agreed to acquire Angel Square, Islington EC1 from Derwent London Plc (LSE:DLN) for £86.5 million.

Founder & Non-Executive Chairman John Burns has left the company

Upcoming dividend of UK£0.52 per share

Full year 2020 earnings released: UK£0.69 loss per share (vs UK£2.54 profit in FY 2019)

Full year 2020 earnings released: UK£0.69 loss per share (vs UK£2.54 profit in FY 2019)

Derwent London plc Proposes Final Dividend for the Year 2020, Payable on June 4, 2021

Derwent London Plc, Annual General Meeting, May 14, 2021

New 90-day high: UK£32.94

Derwent London plc Appoints Mark Breuer as Non-Executive Director of the Company, Effective 1 February 2021

Derwent London plc Appoints Emily Prideaux as Executive Director, with Effect from 1 March 2021

Eurazeo Patrimoine signed a contract to acquire 192,700 sq ft freehold interest in Johnson Building, 77 Hatton Garden and 5-7 St Cross Street EC1 from Derwent London Plc (LSE:DLN) for £170 million.

Co-Founder recently sold UK£387k worth of stock

Derwent London Plc to Report Fiscal Year 2020 Results on Feb 25, 2021

Winten Limited cancelled its unsolicited takeover proposal to acquire the remaining 97.13% stake in Derwent Valley Holdings plc for approximately £397.95 million.

WestInvest ImmoValue, a fund managed by Deka Immobilien GmbH completed the acquisition of 40 Chancery Lane WC2 in London from Derwent London Plc (LSE:DLN).

Lloyd Dorfman and family exchanged contracts to acquire 2 & 4 Soho Place from Derwent London Plc (LSE:DLN) for £40.5 million.

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken